Panacos Pharmaceuticals

Advancement of antiretroviral therapies for HIV has become a double-edged sword for some patients, as patients living longer and better with the virus can outlast the utility of various drugs and comb

DFH Pharma has teamed with the US National Cancer Institute (NCI) to further the development of next-generation HIV maturation inhibitors, a new class of antiretroviral drugs. Under the collaboration,

EpiCept Corporation, focused on the development and commercialisation of treatments for cancer and pain, has appointed Dr Alan Dunton to its board of directors as non-executive chair. Dr Dunton replac

Palatin Technologies has appointed Dr Alan Dunton to its board of directors as an independent director and member of its audit and compensation committees. Dr Dunton is president and principal of Dane